Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Dock Phillip Ellis, best remembered as the winningest pitcher on the champion 1971 Pittsburgh Pirates baseball club, was also one of his sport’s more colorful personalities, although his exploits were generally overshadowed by those of players (Curt Flood, Richie Allen, Reggie Jackson) more talented and more controversial. Ellis’ intolerance for slights which he perceived to be related to the color of his skin was well-established long before he reached the major leagues (he declined to play on his high school’s baseball team because it was coached by a “racist,” and while in the minor leagues he once took a bat into the stands in pursuit of a racially-motivated heckler), and he was the subject of several headline-grabbing altercations during his prime years in the big leagues:    “I know the orders came from [baseball commissioner] Bowie Kuhn, and I don’t like it. Look around, there are fellows who wear white shoes in practice. Some wear jackets. Others don’t wear hats. I wasn’t going to say anything, but since they seem to be aiming in my direction, I’m going to say things. They didn’t put out any orders about Joe Pepitone when he wore a hairpiece down to his shoulders.”    But, oddly enough, the most notorious aspect of Dock Ellis’ playing days wasn’t disclosed until several years after he had retired, and it involved an accomplishment that is usually the highlight of any pitcher’s career. On 12 June 1970, Ellis hurled the first no-hitter of the 1970 season as he blanked the Padres 2-0 in the opening game of a double-header in San Diego. Ellis’ feat was a bit unusual in that he seemed particularly wild that day, walking eight batters and hitting one, but many pitchers have achieved stellar results despite laboring with obvious control problems. (Yankee hurler Bill Bevens came within one out of throwing a no-hitter against Brooklyn in the fourth game of the 1947 World Series despite issuing the Dodgers an astounding ten bases on balls.) In post-game interviews Ellis said he had been thinking about a no-hitter from the fourth inning onward and attributed his wildness to his efforts to keep the ball away from hitters: “I know guys who don’t want to talk about it, but if you’re going to throw [a no-hitter], you’re going to throw it. The ball I was throwing was moving. I was keeping the ball away from the hitters. That’s why I walked so many.” Fourteen years later, however, Dock Ellis revealed an alternative explanation for his lack of control that day: he was under the influence of LSD at the time. According to accounts he gave the press in April 1984, Ellis had spent the morning of 12 June 1970 relaxing in his home town of Los Angeles, under the mistaken belief that the Pirates had the day off. Ellis said he ingested LSD around noon, but at about 1:00 PM his girlfriend picked up a newspaper and discovered that not only were the Pirates scheduled to play a double-header in San Diego that evening, but Ellis was slated to start the first game for Pittsburgh. Ellis’ companion hustled him off to the airport by 3:30 PM and got him on a flight to San Diego, where arrived at 4:30 PM, in time for the double-header’s 6:05 PM start. Ellis told reporters he remembered little of what took place during the game itself:  “I can only remember bits and pieces of the game. I was psyched. I had a feeling of euphoria. I was zeroed in on the [catcher’s] glove, but I didn’t hit the glove too much. I remember hitting a couple of batters and the bases were loaded two or three times. The ball was small sometimes, the ball was large sometimes, sometimes I saw the catcher, sometimes I didn’t. Sometimes I tried to stare the hitter down and throw while I was looking at him. I chewed my gum until it turned to powder. They say I had about three to four fielding chances. I remember diving out of the way of a ball I thought was a line drive. I jumped, but the ball wasn’t hit hard and never reached me.”  Any assignment of a “True” status to this story must be a guarded one: only Dock Ellis knows whether or not he actually took LSD the day he pitched his no-hitter, and even if he did ingest LSD that day, judging the extent to which the drug (which can affect different people in different ways) was affecting him by the time he took part in that evening’s game is problematic. Baseball is a difficult game to play at the major league level, even for skilled professionals free from the effects of mind-altering substances, yet Ellis managed to pitch a complete game that evening, apparently did not act so unusually that his teammates or manager took notice, and was quite lucid while conducting post-game interviews with the press. (Of course, since it’s a long-standing baseball superstition that players should avoid speaking to a teammate who is in the midst of pitching a no-hitter, the other Pirates likely had little or no interaction with Ellis in the dugout during the latter half of the game.) Although Ellis might correctly be described as having been “under the influence of LSD” during his no-hitter, quite possibly the drug’s primary effects had peaked and were wearing off by game time. Dock Ellis’ recollections are also somewhat questionable. Donald Hall’s 1976 biography, Dock Ellis in the Country of Baseball, initially stated that Ellis had been drinking (vodka) before his no-hitter. Ellis maintained that he never pitched again while under the influence of LSD after his 1970 no-hitter, but he later said he had also taken the drug before the 1974 Cincinnati game in which he intentionally threw at the first several batters. And that admission came after he had previously stated that he took “pep pills,” not LSD, before that 1974 game. Then he said in 1985 that he “never pitched a game in the major leagues I wasn’t high.” Claim: Pittsburgh Pirates pitcher Dock Ellis hurled a no-hitter while under the influence of LSD.
An unfortunate aspect of Dock Ellis’ admission is that he is now remembered by many people (especially those too young to have seen him play during his heyday with the Pirates) as “the guy who pitched a no-hitter on drugs,” a characterization which not only slights a baseball career that included some very fine moments, but also obscures the many acts of charity and conscience in which Ellis engaged both during and after his playing days: he worked with the Pennsylvania Department of Corrections to rehabilitate black prisoners, helped start the Black Athletes Foundation for Sickle Cell Research, and served as the coordinator of an anti-drug program in Los Angeles before passing away from liver disease in 2008.

Paragraph: Major U.S. indexes fell about 2 percent and the Dow Jones Industrial Average dropped as much as 563 points. On the benchmark S&P 500 index, health care and technology companies absorbed the worst losses. Johnson & Johnson plunged by the most in 16 years after Reuters reported that the company has known since the 1970s that its talc Baby Powder sometimes contained carcinogenic asbestos. The company denied the report. China said industrial output and retail sales both slowed in November. That could be another sign that China’s trade dispute with the U.S. and tighter lending conditions are chilling its economy, which is the second-largest in the world. Meanwhile, purchasing managers in Europe signaled that economic growth was slipping. Sameer Samana, senior global market strategist for Wells Fargo Investment Institute, said investors are concerned that weakness will make it way to the U.S. They’re wondering if the U.S. economy is likely to run out of steam sooner than they had thought. “Market consensus has been that the next recession is probably in 2020 or beyond,” he said. Now, he said, the market is “really testing that assumption and trying to figure out whether it’s sooner.” Rising interest rates and tighter credit conditions are adding to investors’ nervousness because they both tend to slow down economic growth. This week the European Central Bank said it is ending a bond-buying program that has pumped trillions into Europe’s economy. The Federal Reserve is expected to increase U.S. rates again on Wednesday, as it’s been doing for the last three years. It may also shed light on whether it plans to raise rates further in 2019. For more than 20 years, China has been one of the biggest contributors to growth in the global economy, and when investors see signs the Chinese economy is weakening, they expect it will affect other countries like the U.S. that sell things to China. In Europe, the index of purchase managers fell in France, which is racked by protests, to a level that points toward economic contraction. Germany’s reading still pointed to growth, but it fell to its lowest level in four years. Those reports canceled out some potential good news on trade: the Chinese government announced a 90-day suspension of tariff increases on U.S. cars, trucks and auto imports. It’s part of a cease-fire that China and the U.S. announced earlier this month to give them time to work on other issues. December is typically the best month of the year for stocks as a “Santa Claus rally” often adds to the year’s gains. With 10 trading days left this month, however, the S&P 500 is down 5.8 percent. That followed a small gain in November and a steep 6.9 percent drop in October. The S&P 500 index lost 50.59 points, or 1.9 percent, to 2,599.95, its lowest close since April 2. The Dow retreated 496.87 points, or 2 percent, to 24,100.51. The Dow has fallen 10 percent from its record high in early October, reaching a mark known on Wall Street as a “correction.” The other major U.S. indexes were already in “corrections.” The Nasdaq composite slid 159.67 points, or 2.3 percent, to 6,910.66. The Russell 2000 index of smaller-company stocks fell 21.89 points, or 1.5 percent, to 1,410.81. Johnson & Johnson dropped 10 percent to $133 in very heavy trading. Its market value fell by $40 billion. Reuters reported that court documents and test results show Johnson & Johnson has known for decades that its raw talc and finished Baby Powder sometimes contained asbestos, but that the company didn’t inform regulators or the public. The company called the story “false and inflammatory.” In July the company lost a lawsuit from plaintiffs who argued that its products were linked to cases of ovarian cancer and mesothelioma. A St. Louis jury awarded plaintiffs $4.7 billion. Johnson & Johnson faces thousands of other lawsuits. Among technology companies, Apple dipped 3.2 percent to $165.48. Adobe skidded 7.3 percent to $230 after its fourth-quarter profit disappointed investors and it also forecast lower-than-expected earnings in the current fiscal year. Industrial companies sank as well. Boeing lost 2.1 percent to $318.75. Oil prices again turned lower, as a slower global economy would weaken demand for oil and other fuels. Benchmark U.S. crude fell 2.6 percent to $51.20 a barrel in New York. Brent crude, used to price international oils, dropped 1.9 percent to settle at $60.28 a barrel in London. European Union leaders rejected British Prime Minister Theresa May’s request to make changes to their deal covering Britain’s departure from the EU on March 29. British legislators aren’t satisfied with the terms May negotiated, and she canceled a scheduled vote earlier this week because it was clear Parliament wouldn’t approve it. Britain’s economy and financial markets across Europe face severe disruption without an agreement. In other trading: —European bond prices rose and yields fell. Both the British pound and the euro weakened. The pound slipped to $1.2579 from $1.2660 and the euro fell to $1.1303 from $1.1367. —Germany’s DAX declined 0.5 percent and the CAC 40 in France declined 0.8 percent. Britain’s FTSE 100 fell 0.5 percent. —Japan’s Nikkei 225 index slid 2 percent and the Kospi in South Korea lost 1.3 percent. Hong Kong’s Hang Seng was down 1.6 percent. —Bond prices edged higher. The yield on the 10-year Treasury note fell to 2.89 percent 2.90 percent. —In other commodities trading, wholesale gasoline lost 3 percent to $1.43 a gallon. Heating oil fell 1.7 percent to $1.85 a gallon and natural gas dropped 7.2 percent to $3.83 per 1,000 cubic feet. —Gold fell 0.5 percent to $1,241.40 an ounce. Silver dipped 1.5 percent to $14.64 an ounce. Copper was little changed at $2.77 a pound. —The dollar fell to 113.29 yen from 113.60 yen. ____ Associated Press Writer Josh Boak contributed to this report from Washington. ___ AP Markets Writer Marley Jay can be reached at http://twitter.com/MarleyJayAP Claim: Stocks plunge to 8-month lows on growth fears; J&J nosedives.
Stocks staggered to eight-month lows Friday after weak economic data from China and Europe set off more worries about the global economy. Mounting tensions in Europe over Britain’s impending departure from the European Union also darkened traders’ moods.

Paragraph: More than 2 percent of patients undergoing non-cardiac  vascular surgery — surgery to arteries and veins — die from  heart attacks and other cardiovascular problems. Lescol, a so-called statin drug, appears to be effective in  reducing this risk by cutting inflammation and stabilizing  plaques in coronary arteries that might otherwise rupture, Don  Poldermans of the Erasmus Medical Centre in Rotterdam said. Results of a 500-patient study presented by Poldermans at  the annual meeting of the European Society of Cardiology showed  only 10.9 percent of vascular surgery patients taking Lescol  suffered myocardial ischemia — reduced blood supply to the  heart muscle — against 18.9 percent of those on placebo. Lescol is less potent than some other statin drugs but  patients in the study were given the highest dose of the  medicine as an extended release formulation, which lasts around  four days. Lescol, known generically as fluvastatin, is one of  Novartis’s older products. Sales in 2007 totaled $665 million,  down 8 percent on a year earlier. Claim: Novartis's Lescol drug protects heart after surgery.

Giving patients Novartis’s  anti-cholesterol drug Lescol after major vascular surgery  reduces the risk of serious heart problems, researchers said on  Monday.